|
http://theoncologist.alphamedpre ... abstract/15/12/1352
,
2009 7月美国批准使用培美曲塞作为局部晚期/转移性非鳞状非小细胞肺癌 经过四个疗程的铂类药物化疗后稳定的患者的维持疗法。患者存活时间明显延长。
On July 2, 2009, the U.S. Food and Drug Administration approved pemetrexed injection (Alimta® Injection; Eli Lilly and Company, Indianapolis, IN) for maintenance treatment of patients with locally advanced or metastatic nonsquamous non-small cell lung cancer whose disease has not progressed after four cycles of platinum-based doublet induction chemotherapy. |
|